Sugita K - Search Results

1

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.

Furuichi Y, Goi K, Inukai T, Sato H, Nemoto A, Takahashi K, Akahane K, Hirose K, Honna H, Kuroda I, Zhang X, Kagami K, Hayashi Y, Harigaya K, Nakazawa S, Sugita K. Furuichi Y, et al. Among authors: sugita k. Cancer Res. 2007 Oct 15;67(20):9852-61. doi: 10.1158/0008-5472.CAN-07-0105. Cancer Res. 2007. PMID: 17942916

2

Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.

Akahane K, Inukai T, Zhang X, Hirose K, Kuroda I, Goi K, Honna H, Kagami K, Nakazawa S, Endo K, Kubota T, Yagita H, Koyama-Okazaki T, Sugita K. Akahane K, et al. Among authors: sugita k. Exp Hematol. 2010 Oct;38(10):885-95. doi: 10.1016/j.exphem.2010.06.014. Epub 2010 Jul 27. Exp Hematol. 2010. PMID: 20670671

3

Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemias.

Nemoto A, Inukai T, Uno K, Kiyokawa N, Miyagawa Y, Takahashi K, Sato H, Akahane K, Hirose K, Honna-Oshiro H, Goi K, Kagami K, Nakazawa S, Fujimoto J, Inaba T, Sugita K. Nemoto A, et al. Among authors: sugita k. Leuk Res. 2013 Jan;37(1):93-101. doi: 10.1016/j.leukres.2012.10.001. Epub 2012 Oct 23. Leuk Res. 2013. PMID: 23099235

4

Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia.

Nemoto A, Saida S, Kato I, Kikuchi J, Furukawa Y, Maeda Y, Akahane K, Honna-Oshiro H, Goi K, Kagami K, Kimura S, Sato Y, Okabe S, Niwa A, Watanabe K, Nakahata T, Heike T, Sugita K, Inukai T. Nemoto A, et al. Among authors: sugita k. Mol Cancer Ther. 2016 Jan;15(1):94-105. doi: 10.1158/1535-7163.MCT-14-1065. Epub 2015 Dec 4. Mol Cancer Ther. 2016. PMID: 26637365

5

Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.

Huang M, Inukai T, Miyake K, Tanaka Y, Kagami K, Abe M, Goto H, Minegishi M, Iwamoto S, Sugihara E, Watanabe A, Somazu S, Shinohara T, Oshiro H, Akahane K, Goi K, Sugita K. Huang M, et al. Among authors: sugita k. Cancer Med. 2018 Apr;7(4):1297-1316. doi: 10.1002/cam4.1323. Epub 2018 Feb 23. Cancer Med. 2018. PMID: 29473342 Free PMC article.

6

Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.

Ando N, Furuichi Y, Kasai S, Tamai M, Harama D, Kagami K, Abe M, Goi K, Inukai T, Sugita K. Ando N, et al. Among authors: sugita k. Leuk Res. 2018 Dec;75:36-44. doi: 10.1016/j.leukres.2018.11.001. Epub 2018 Nov 3. Leuk Res. 2018. PMID: 30453100

7

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity.

Inukai T, Zhang X, Goto M, Hirose K, Uno K, Akahane K, Nemoto A, Goi K, Sato H, Takahashi K, Honna H, Kagami K, Nakamoto K, Yagita H, Okumura K, Koyama-Okazaki T, Nakazawa S, Sugita K. Inukai T, et al. Among authors: sugita k. Leukemia. 2006 Dec;20(12):2119-29. doi: 10.1038/sj.leu.2404429. Epub 2006 Oct 26. Leukemia. 2006. PMID: 17066095

8

TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.

Tamai M, Furuichi Y, Kasai S, Ando N, Harama D, Goi K, Inukai T, Kagami K, Abe M, Ichikawa H, Sugita K. Tamai M, et al. Among authors: sugita k. Leuk Res. 2017 Oct;61:68-76. doi: 10.1016/j.leukres.2017.08.013. Epub 2017 Sep 14. Leuk Res. 2017. PMID: 28917156

9

Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements.

Tsutsumi S, Taketani T, Nishimura K, Ge X, Taki T, Sugita K, Ishii E, Hanada R, Ohki M, Aburatani H, Hayashi Y. Tsutsumi S, et al. Among authors: sugita k. Cancer Res. 2003 Aug 15;63(16):4882-7. Cancer Res. 2003. PMID: 12941810

10

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.

Taketani T, Taki T, Sugita K, Furuichi Y, Ishii E, Hanada R, Tsuchida M, Sugita K, Ida K, Hayashi Y. Taketani T, et al. Among authors: sugita k. Blood. 2004 Feb 1;103(3):1085-8. doi: 10.1182/blood-2003-02-0418. Epub 2003 Sep 22. Blood. 2004. PMID: 14504097 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,440 results

Search Page